Validation experiment designed to validate causal mechanisms targeting P2rx7 in PS19 tauopathy mice. Primary outcome: Brain atrophy, tau accumulation, and cognitive impairment
This experiment examined the effects of genetic deletion of P2rx7 in PS19 tauopathy mice, a mouse model of Alzheimer's disease. Researchers compared PS19 mice with intact P2rx7 to those with genetic deletion of P2rx7, measuring brain atrophy, tau accumulation, and cognitive function. The study aimed to determine whether P2rx7 deletion could mitigate the pathological features of tauopathy. Behavioral assessments were likely conducted to evaluate cognitive impairment, while histological and biochemical analyses were performed to assess brain atrophy and tau protein accumulation in various brain regions.
Genetic deletion of P2rx7 in PS19 mice followed by behavioral testing, histological analysis, and tau protein quantification
P2rx7 deletion would reduce brain atrophy, tau accumulation, and cognitive deficits
Significant reduction in pathological markers and improved cognitive performance in P2rx7-deleted mice
No debates yet
No results recorded yet. Use POST /api/experiments/{id}/results to record a result.